Probable Creutzfeldt-Jakob Disease in a Resource-Limited Setting: A Case Report and Diagnostic Challenges
PDF
PDF

Keywords

Prions
Dementia
Rapidly Progressive
Myoclonus
Magnetic Resonance Imaging
Creutzfeldt-Jakob Disease

How to Cite

Zambrana Campana, A., Bordon Ortiz, G. E., & Ortega-Martinez, R. A. (2026). Probable Creutzfeldt-Jakob Disease in a Resource-Limited Setting: A Case Report and Diagnostic Challenges. SAP Primary Care, 2, 90. https://doi.org/10.62486/pc202690

Abstract

Creutzfeldt-Jakob disease is a rare, transmissible, and invariably fatal spongiform encephalopathy caused by the accumulation of abnormal prion proteins in the central nervous system. We report the case of a middle-aged female patient from eastern Bolivia who presented with a six-month history of diplopia, progressive ataxia, generalized myoclonus, and rapidly progressive cognitive decline. A comprehensive diagnostic workup excluded infectious, metabolic, and autoimmune etiologies. Electroencephalography revealed periodic triphasic complexes, while brain magnetic resonance imaging demonstrated bilateral hyperintensities in the basal ganglia and cortical involvement, findings highly suggestive of Creutzfeldt-Jakob disease. According to the 2018 diagnostic criteria of the National Creutzfeldt-Jakob Disease Research & Surveillance Unit, the case was classified as probable prion disease. Neuropathological confirmation was not feasible due to logistical constraints. This case highlights the importance of considering prion diseases in the differential diagnosis of rapidly progressive dementias, particularly in low-resource settings where clinical assessment and neuroimaging play a central diagnostic role.

PDF
PDF

References

1. Jurcau MC, Jurcau A, Diaconu RG, Hogea VO, Nunkoo VS. A Systematic Review of Sporadic Creutzfeldt-Jakob Disease: Pathogenesis, Diagnosis, and Therapeutic Attempts. Neurol Int. 2024 Sep 20;16(5):1039-1065. doi: 10.3390/neurolint16050079.

2. Mastrangelo A, Mammana A, Baiardi S, Tiple D, Colaizzo E, Rossi M, Vaianella L, Polischi B, Equestre M, Poleggi A, Capellari S, Ladogana A, Parchi P. Evaluation of the impact of CSF prion RT-QuIC and amended criteria on the clinical diagnosis of Creutzfeldt-Jakob disease: a 10-year study in Italy. J Neurol Neurosurg Psychiatry. 2023 Feb;94(2):121-129. doi: 10.1136/jnnp-2022-330153.

3. Shimamura MI, Parchi P, Zerr I. Advancing early detection of prion diseases: emerging biomarkers and diagnostic criteria. Int J Mol Sci. 2025;26(5):2037. doi:10.3390/ijms26052037

4. Lizarazo J, Vargas AX, Olarte R, Lizarazo DA. Determination of prion proteins in the diagnosis of Creutzfeldt-Jakob disease using RT-QuIC: a case report from northeastern Colombia. Biomédica. 2024;44(4):434-440. Disponible en: https://revistabiomedica.org/index.php/biomedica/article/view/6931

5. Castillo CCT. Tasa de mortalidad por enfermedad de Creutzfeldt-Jakob entre los años 2021-2024 en Chile: una mirada a la epidemiología nacional. Rev ANACEM. 2025;19(1):61. doi:10.70536/RevANACEM/V19N1-202561

6. Kicherova OA, Kichigina NA, Illarioshkin SN. Difficulties in the in-life diagnosis of Creutzfeldt-Jakob disease. Neurol Sci. 2025;46(7):3819-3829. doi:10.1007/s11055-025-01815-x

7. Zerr I, Hermann P, Steinhoff BJ. Advances in biomarkers for diagnosis and prognosis of prion diseases. Lancet Neurol. 2026;25:400-406. doi:10.1016/S1474-4422(25)00406-5

8. Noor H, Baqai MH, Naveed H, Naveed T, Rehman SS, Aslam MS, Lakdawala FM, Memon WA, Rani S, Khan H, Imran A, Farooqui SK. Creutzfeldt-Jakob disease: A comprehensive review of current understanding and research. J Neurol Sci. 2024 Dec 15;467:123293. doi: 10.1016/j.jns.2024.123293.

9. Geschwind MD. Rapidly Progressive Dementia. Continuum (Minneap Minn). 2016 Apr;22(2 Dementia):510-37. doi: 10.1212/CON.0000000000000319.

10. Paterson RW, Takada LT, Geschwind MD. Diagnosis and treatment of rapidly progressive dementias. Neurol Clin Pract. 2012 Sep;2(3):187-200. doi: 10.1212/CPJ.0b013e31826b2ae8.

11. Meissner B, Kallenberg K, Sanchez-Juan P, Collie D, Summers DM, Almonti S, Collins SJ, Smith P, Cras P, Jansen GH, Brandel JP, Coulthart MB, Roberts H, Van Everbroeck B, Galanaud D, Mellina V, Will RG, Zerr I. MRI lesion profiles in sporadic Creutzfeldt-Jakob disease. Neurology. 2009 Jun 9;72(23):1994-2001. doi: 10.1212/WNL.0b013e3181a96e5d.

12. Zerr I, Kallenberg K, Summers DM, et al. Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Brain. 2009;132(Pt 10):2659-2668. doi:10.1093/brain/awp191

13. Thompson A, MacKay A, Rudge P, Lukic A, Porter MC, Lowe J, Collinge J, Mead S. Behavioral and psychiatric symptoms in prion disease. Am J Psychiatry. 2014 Mar;171(3):265-74. doi: 10.1176/appi.ajp.2013.12111460.

14. National Creutzfeldt-Jakob Disease Research & Surveillance Unit (NCJDRSU). Diagnostic criteria for sporadic CJD (2018). Edinburgh: University of Edinburgh [Internet]. Disponible en: https://www.cjd.ed.ac.uk/sites/default/files/criteria_0.pdf [Consultado el 10 de enero de 2026].

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.